Bone metabolism and arterial stiffness after renal transplantation

BACKGROUND/AIMS: To assess the relationship between bone and vascular disease and its changes over time after renal transplantation. Metabolic bone disease (MBD) is common in chronic kidney disease (CKD) and is associated with cardiovascular (CV) disease. Following transplantation (Tx), improvement in CV disease has been reported; however, data regarding changes in bone disease remain controversial.

METHODS: Bone turnover and arterial stiffness (pulse wave velocity (PWV)) were assessed in 47 Tx patients (38 (3-191) months after Tx).

RESULTS: Bone alkaline phosphatase (BALP), osteocalcin (OC) and beta-crosslaps were significantly higher in Tx patients, and decreased significantly after one year. There was a negative correlation between BALP, OC and steroid administered (r = -0.35; r = -0.36 respectively). PWV increased in the Tx group (1.15 SD). In patients with a follow up of <24 months, PWV was correlated with BALP and beta-crosslaps (r=0.53; r = 0.69 respectively) while in the ≥24 months group, PWV was correlated with cholesterol (r=0.38).

CONCLUSIONS: Increased bone turnover and arterial stiffness are present following kidney transplantation. While bone turnover decreases with time, arterial stiffness correlates initially with bone turnover, after which the influence of cholesterol becomes significant. Non-invasive estimation of bone metabolism and arterial stiffness may help to assess CKD-MBD following renal transplantation.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Kidney & blood pressure research - 39(2014), 6 vom: 23., Seite 507-15

Sprache:

Englisch

Beteiligte Personen:

Cseprekál, Orsolya [VerfasserIn]
Kis, Eva [VerfasserIn]
Dégi, Arianna A [VerfasserIn]
Kerti, Andrea [VerfasserIn]
Szabó, Attila J [VerfasserIn]
Reusz, György S [VerfasserIn]

Links:

Volltext

Themen:

104982-03-8
9007-34-5
97C5T2UQ7J
Alkaline Phosphatase
Cholesterol
Collagen
EC 3.1.3.1
Glutamyl-lysyl-alanyl-histidyl-aspartyl-glycyl-glycyl-arginine
Journal Article
Osteocalcin
Peptide Fragments
Research Support, Non-U.S. Gov't
Steroids

Anmerkungen:

Date Completed 08.09.2015

Date Revised 09.01.2015

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1159/000368461

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM244794693